Thrombophilia classification: Difference between revisions
Jump to navigation
Jump to search
(minor edit) |
(minor) |
||
| Line 11: | Line 11: | ||
:*Acquired thrombophilia or secondary hypercoagulable state | :*Acquired thrombophilia or secondary hypercoagulable state | ||
:*Mixed/Unknown | :*Mixed/Unknown | ||
*Different thrombophilic states are associated with venous or both venous and arterial clots | |||
{| class="wikitable" | {| class="wikitable" | ||
| Line 30: | Line 30: | ||
| Antithrombin deficiency | | Antithrombin deficiency | ||
| Trauma/major surgery | | Trauma/major surgery | ||
| Increased factor VIII | | Increased factor VIII levels | ||
|- | |- | ||
| Protein C and protein S deficiency | | Protein C and protein S deficiency | ||
| Orthopedic surgery | | Orthopedic surgery | ||
| Increased factor XI | | Increased factor XI levels | ||
|- | |- | ||
| Dysfibrinogenemia | | Dysfibrinogenemia | ||
| Malignancy | | Malignancy | ||
| Increased factor IX | | Increased factor IX levels | ||
|- | |- | ||
| | | | ||
| Line 117: | Line 117: | ||
{| class="wikitable" | {| class="wikitable" | ||
! Thrombophilic state | ! Thrombophilic state | ||
! Thrombotic risk | ! Thrombotic risk<ref name="pmid15254285">{{cite journal| author=Bates SM, Ginsberg JS| title=Clinical practice. Treatment of deep-vein thrombosis. | journal=N Engl J Med | year= 2004 | volume= 351 | issue= 3 | pages= 268-77 | pmid=15254285 | doi=10.1056/NEJMcp031676 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15254285 }} </ref> | ||
|- | |- | ||
| Trauma/General surgery | | Trauma/General surgery | ||
| Line 141: | Line 141: | ||
|- | |- | ||
| Homocysteinemia | | Homocysteinemia | ||
| Modest | |||
|- | |||
| Increased factor VIII levels | |||
| Modest | |||
|- | |||
| Increased factor IX levels | |||
| Modest | |||
|- | |||
| Increased factor XI levels | |||
| Modest | | Modest | ||
|- | |- | ||
| Protein C and S deficiency | | Protein C and S deficiency | ||
| Intermediate | |||
|- | |||
| Dysfibrogenemia | |||
| Intermediate | | Intermediate | ||
|- | |- | ||
| Line 168: | Line 180: | ||
|- | |- | ||
|} | |} | ||
==References== | ==References== | ||
Revision as of 19:07, 23 June 2016
|
Thrombophilia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thrombophilia classification On the Web |
|
American Roentgen Ray Society Images of Thrombophilia classification |
|
Risk calculators and risk factors for Thrombophilia classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Asiri Ediriwickrema, M.D., M.H.S. [2]
Overview
Thrombophilias are classified as either inherited or a primary hypercoagulable state, acquired or a secondary hypercoagulable state, or mixed/unknown. Certain conditions are associated with greater thrombotic risks and both venous and arterial clots.
Classification
- Thrombophilia can be classified in various forms[1].
- Inherited thrombophilia or primary hypercoagulable state
- Acquired thrombophilia or secondary hypercoagulable state
- Mixed/Unknown
- Different thrombophilic states are associated with venous or both venous and arterial clots
| Thrombophilia Classification | ||
|---|---|---|
| Inherited (Primary) | Acquired (Secondary) | Mixed/Unknown |
| Activated protein C (APC) resistance (Factor V Leiden) | Age | Hyperhomocysteinemia |
| Prothrombin gene mutation (Prothrombin G20210A) | Immobilization | APC resistance unrelated to Factor V Leiden. |
| Antithrombin deficiency | Trauma/major surgery | Increased factor VIII levels |
| Protein C and protein S deficiency | Orthopedic surgery | Increased factor XI levels |
| Dysfibrinogenemia | Malignancy | Increased factor IX levels |
| Myeloproliferative disorders (polycythemia vera, essential thrombocythemia, hyperviscosity) | Increased levels of thrombin-activatable fibrinolysis inhibitor (TAFI) | |
| Pregnancy | Decreased levels of free tissue factor pathway inhibitor (TFPI) | |
| Estrogen and testosterone (oral contraceptives and hormone replacement therapy) | ||
| Obesity | ||
| Heart Failure | ||
| Cirrhosis | ||
| Chronic renal disease (nephrotic syndrome) | ||
| Antiphospholipid syndrome (APLS) or lupus anticoagulant | ||
| Heparin induced thrombocytopenia (HIT) | ||
| Disseminated intravascular coagulopathy (DIC) | ||
| Paroxysmal nocturnal hemoglobinuria (PNH) | ||
| Vasculitis | ||
| Thrombotic microangiopathy | ||
| Drug related (chemotherapies including L-aspariginase, mitomycin, infusion of clotting factors including prothrombin complex concentrates, cryoprecipitate) | ||
| Thrombophilic states associated with arterial clots |
|---|
| APLS and lupus anticoagulant |
| HIT |
| DIC |
| PNH |
| Cold agglutinins (associated with mycoplasma infections) |
| Vasculitis |
| Hyperhomocysteinemia |
| Thrombophilic state | Thrombotic risk[2] |
|---|---|
| Trauma/General surgery | Modest |
| Age > 60 | Modest |
| Immobilization | Modest |
| Pregnancy | Modest |
| Hormone therapies | Modest |
| Factor V Leiden heterozygosity | Modest |
| Prothrombin mutation | Modest |
| Homocysteinemia | Modest |
| Increased factor VIII levels | Modest |
| Increased factor IX levels | Modest |
| Increased factor XI levels | Modest |
| Protein C and S deficiency | Intermediate |
| Dysfibrogenemia | Intermediate |
| Malignancy | High |
| APLS/Lupus anticoagulant | High |
| Myeloproliferative disorders/hyperviscosity | High |
| PNH | High |
| Orthopedic surgery | High |
| Antithrombin deficiency | High |
| Factor V Leiden homozygosity | High |
References
- ↑ Hoffman R, Benz EJ, Shattil SJ, et al. Hematology: Basic Principles and Practice: Elsevier Science Health Science Division; 2004.
- ↑ Bates SM, Ginsberg JS (2004). "Clinical practice. Treatment of deep-vein thrombosis". N Engl J Med. 351 (3): 268–77. doi:10.1056/NEJMcp031676. PMID 15254285.